These results, along with a former report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 assist the idea of targeting ACKR3 as a unique solution to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-similar Diseases. Conolidine CONOCB2™ essentially performs by https://annieu951sjy6.wikiconverse.com/user